ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management
The DOI matches its Crossref record, with a small difference in title or year; 208 of the 210 references it cites were found in a registry or an index.
Abstract
Available information from 1980 to 1997 on angiotensin converting enzyme (ACE) inhibitor-induced angioedema and its underlying mechanisms are summarised and discussed. The incidence of angioedema is low (0.1 to 0.2%) but can be considered as a potentially life-threatening adverse effect of ACE inhibitor therapy. This adverse effect of ACE inhibitors, irrespective of the chemical structure, can occur early in treatment as well as after prolonged exposure for up to several years. The estimate incidence is quite underestimated. The actual incidence can be far higher because of poorly recognised presentation of angioedema as a consequence of its late onset in combination with usually long term therapy. Also, a spontaneous reporting bias can contribute to an actual higher incidence of this phenomenon. The incidence can be even higher (up to 3-fold) in certain risk groups, for instance Black Americans. Treatment includes immediate withdrawal of the ACE inhibitor and acute symptomatic supportive therapy followed by immediate (and long term) alternative therapy with other classes of drugs to manage hypertension and/or heart failure. Preclinical and clinical studies for the elucidation of the underlying mechanism(s) of ACE inhibitor-associated angioedema have not generated definite conclusions. It is suggested that immunological processes and several mediator systems (bradykinin, histamine, substance P and prostaglandins) are involved in the pathogenesis of angioedema. A great part of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Angiotensin I-converting enzyme inhibitors (ACEi) are widely used antihypertensive agents that are associated with a potentially life-threatening reaction, ACEi-angioedema.”
From A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema (2011) · cites this paper as Vleeming et al., 1998
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767 · cited 2×
“[195-198] Both the amount of immunoreactive ACE,[194,199] and catalytic activity[198] are related to I/D genetic polymorphism.”
BackgroundCambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Pharmacology of bradykinin and related kinins.
Regoli, D., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,892 · cited 1×
“[142,143] In healthy and hypertensive humans ACE inhibitors potentiate the blood pressure lowering effect of bradykinin approximately 20- to 50fold.”
BackgroundAllergy: Principles and Practice.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_10 · Cited by 1,696
Rook, A., Wilkinson, D. S., & Ebling, F. J. G. (1968) · Medical Entomology and Zoology · Cited by 1,610
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,608
Tiret, L., Rigat, B. A., Visvikis‐Siest, S., Breda, C., Corvol, P. L., Cambien, F., & Soubrier, F. (1992) · Europe PMC (PubMed Central) · Cited by 1,174
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
Hereditary Angioedema: the Clinical Syndrome and Its Management
FRANK, M. M., GELFAND, J. A., & ATKINSON, J. P. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-5-580 · Cited by 615 · cited 1×
“[130-132] C1-EI inhibits the cleaving of the first component of the complement into its active form which then activates C4, C2 and the rest of the complement cascade.”
Background
Cited by
BSACI guideline for the management of chronic urticaria and angioedema
Powell, R. J., Leech, S. C., Till, S., Huber, P. A. J., Nasser, S. M., & Clark, A. T. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12494 · Cited by 377
Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis
Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L., & Powe, N. R. (2003) · JAMA · doi:10.1001/jama.290.23.3101 · Cited by 381
Incidence and Characteristics of Angioedema Associated With Enalapril
Kostis, J. B., Kim, H. J., Rusnak, J., Casale, T., Kaplan, A., Corren, J., & Levy, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1637 · Cited by 291
A dverse D rug R eactions in the O rofacial R egion
Scully, C., & Bagan, J.-V. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500405 · Cited by 254
A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema
Baş, M., Greve, J., Stelter, K., Havel, M., Strassen, U., Rotter, N., Veit, J., Schossow, B., Hapfelmeier, A., Kehl, V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1312524 · Cited by 253
Metadata
- Authors
- Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J.
- Affiliations
- National Institute for Public Health and the Environment (NL)
- Erasmus University Rotterdam (NL)
- Corresponding author
- Vleeming, Wim
- ORCID
- Stricker, Bruno H.
- Venue
- Drug Safety
- Published
- 1998
- Volume
- 18
- Issue
- 3
- Pages
- 171-188
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W2091790017
- Cited by
- 243
- References
- 210
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 13 · 2014: 8 · 2013: 14 · 2012: 8
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- ACE inhibitor-induced angioedema, ACE inhibitors, adverse drug reactions, bradykinin, histamine, substance P, prostaglandins, ACE gene polymorphism, pharmacogenetics, hypertension, heart failure, drug withdrawal, incidence, African Americans
- MeSH terms
- Angioedema, Angiotensin-Converting Enzyme Inhibitors, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management. https://app.cochat.ai/papers/10.2165/00002018-199818030-00003
- The paper
- Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J. (1998). ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management. Drug Safety. https://doi.org/10.2165/00002018-199818030-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.